]>
IRCT20150706023084N19 IRCT 2024-05-09 Barij Essence Pharmaceutical company The use of viola odorata syrup on depression The use of viola odorata syrup on depression in hospitals and clinics affiliated to the Islamic Azad University of Tehran 2024-05-21 anticipated 60 Complete https://irct.ir/trial/75348 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: To randomize the study, each patient is assigned a code(1 or 2) using Rand number. Conventionally, the patient who received code one will receive drug and the patient who received code two will receive placebo. It should be noted that the patients will not know what code they have received and only the researcher will be aware of this issue, Blinding description: This study will be single blinded in such a way that the participants will not be aware of the contents of the medicine package they receive. A code will be assigned to each patient using Rand number. Patients with a code of 1 will receive the drug, while patients with a code of 2 will receive a placebo. 3 depression. Intervention 1: Intervention group: 30 patients over 15 years old with mild to moderate depression, confirmed by a psychiatrist, will be selected to use a Viola Odorata syrup made by Barij Essence Pharmaceutical Company once a day for a period of 3 months, in addition to taking an SSRI medication. Their improvement will be evaluated every two weeks through a Beck questionnaire. Intervention 2: Control group: 30 patients in the control group will receive the SSRI drug, similar to the intervention group. However, instead of receiving Viola Odorata syrup, they will receive a placebo syrup made by Barij Essence Pharmaceutical Company once a day for 3 months. Yes - There is a plan to make this available What will be shared: Data are collected in the form of a questionnaire When: After the intervention To whom: Qualified persons Conditions: Use for scientific advancement in the field under study Where to obtain: Clinical office of Islamic Azad University Medical science of Tehran -Faculty of Pharmacy How to obtain: Request in writing by going through legal procedures Comments:
public Maryam Shiehmorteza
No.99, Yakhchal street, Dr Shariati Ave.
Tehran Iran (Islamic Republic of) 1916893813 +98 21 2263 3986 shiehmorteza@iaups.ac.ir Islamic Azad University scientific Maryam Shiehmorteza
No.99,Yakhchal Street., Dr shariati Ave.
تهران Iran (Islamic Republic of) 1916893813 +98 21 2264 0056 nazarizeynab32@gmail.com Islamic Azad University Iran (Islamic Republic of) Minor to moderate depression disorder Use of SSRIs by control group Age range over 15 years 15 years no limit Both Pregnant women Breast feeding women GFR under 30 & child pugh B - C (Renal & Liver failure) F32.0 Major depressive disorder, single episode, mild Treatment - Drugs Placebo Intervention group: 30 patients over 15 years old with mild to moderate depression, confirmed by a psychiatrist, will be selected to use a Viola Odorata syrup made by Barij Essence Pharmaceutical Company once a day for a period of 3 months, in addition to taking an SSRI medication. Their improvement will be evaluated every two weeks through a Beck questionnaire. Control group: 30 patients in the control group will receive the SSRI drug, similar to the intervention group. However, instead of receiving Viola Odorata syrup, they will receive a placebo syrup made by Barij Essence Pharmaceutical Company once a day for 3 months. Depression recovery degree according to Beck questionnaire. Timepoint: 14 day. Method of measurement: Beck depression questionnaire. Barij Essence Pharmaceutical company Approved 2023-12-27 کمیته اخلاق واحد علوم دارویی دانشگاه علوم پزشکی آزاد اسلامی تهران Dr Shariati Ave., Gholhak, Yakhchal Ave., Islamic Azad University of Pharmaceutical Sciences Branch Tehran Tehran Iran (Islamic Republic of)